<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Site da Brakke Consulting</provider_name><provider_url>https://brakkeconsulting.com/pt</provider_url><title>News from Brakke Consulting</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="9hVKcE4ChA"&gt;&lt;a href="https://brakkeconsulting.com/pt/20046/"&gt;Not&#xED;cias e notas sobre sa&#xFA;de animal de 3 de setembro de 2004&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/pt/20046/embed/#?secret=9hVKcE4ChA" width="600" height="338" title="&#x201C;Animal Health News &amp; Notes for September 3, 2004&#x201D; &#x2014; Brakke Consulting Website" data-secret="9hVKcE4ChA" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;</html><description>printer friendly version ******************************************************************* &nbsp;Brakke Consulting&rsquo;s &nbsp;Animal Health News &amp; Notes for September 3, 2004 &nbsp;Copyright &copy; Brakke Consulting, Inc. &nbsp;******************************************************************* IN THE NEWS: &nbsp; earnings news: Bayer Del Monte Ridley Swift &amp; Co. &nbsp; other news: Agri Laboratories Bioniche Life Sciences Bommeli Cargill Central Garden Cross Vetpharm Energy Savers Unlimited Frontier Beef Systems GenVec IDEXX Intervet Merial Pfizer Seara Alimentos Tridelta Tyson &nbsp; &nbsp; ****************************************************************** COMPANY EARNINGS RELEASES &nbsp; &gt;&nbsp; Bayer reported results for the second quarter and first half of 2004.&nbsp; Sales for its Animal Health division were 225 million euros ($272 million), an increase of 5% compared to the second quarter of 2003, due largely to stronger demand in North America.&nbsp; Sales increased 9% in local currencies.&nbsp; Advantix and Baycox continued to perform well.&nbsp; For the first half of 2004, Animal Health sales were 403 million euros ($487 million), an increase of 2.5% compared to the first half of 2003.&nbsp; (company website)&nbsp; &nbsp; &gt;&nbsp; Ridley Inc. reported results for its fiscal 2004 year and fourth quarter ended June 30, 2004.&nbsp; Sales revenues for the year declined by 8.2% in fiscal 2004 to C$610 million (US$454 million) from C$665 million (US$494 million) in fiscal 2003. Feed sales volumes decreased in fiscal 2004 by 8.1% overall. Net earnings for fiscal 2004 were C$10.9 million (US$8.1 million), compared with C$10.4View Full Post;</description></oembed>
